{
    "id": "3b7b662b-8390-4168-b31e-ba430febc1a1",
    "code": {
        "code": "34391-3",
        "codeSystem": "2.16.840.1.113883.6.1",
        "displayName": "HUMAN PRESCRIPTION DRUG LABEL"
    },
    "organization": "Bryant Ranch Prepack",
    "effectiveTime": "20240430",
    "ingredients": [
        {
            "name": "IVERMECTIN",
            "code": "8883YP2R6D",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_6078"
        },
        {
            "name": "CETYL ALCOHOL",
            "code": "936JST6JCN",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30879"
        },
        {
            "name": "CITRIC ACID MONOHYDRATE",
            "code": "2968PHW8QP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_37527"
        },
        {
            "name": "DIMETHICONE",
            "code": "92RU3N3Y1O",
            "chebi_id": null,
            "drugbank_id": "DB11074"
        },
        {
            "name": "EDETATE DISODIUM",
            "code": "7FLD91C86K",
            "chebi_id": null,
            "drugbank_id": "DB13404"
        },
        {
            "name": "GLYCERIN",
            "code": "PDC6A3C0OX",
            "chebi_id": null,
            "drugbank_id": "DB09462"
        },
        {
            "name": "ISOPROPYL PALMITATE",
            "code": "8CRQ2TH63M",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_84262"
        },
        {
            "name": "METHYLPARABEN",
            "code": "A2I8C7HI9T",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_31835"
        },
        {
            "name": "OLEYL ALCOHOL",
            "code": "172F2WN8DV",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30879"
        },
        {
            "name": "PHENOXYETHANOL",
            "code": "HIE492ZZ3T",
            "chebi_id": null,
            "drugbank_id": "DB11304"
        },
        {
            "name": "POLYOXYL 20 CETOSTEARYL ETHER",
            "code": "YRC528SWUY",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_25698"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "PROPYLPARABEN",
            "code": "Z8IX2SC1OH",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32063"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_15377"
        },
        {
            "name": "SODIUM HYDROXIDE",
            "code": "55X04QC32I",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_16234"
        },
        {
            "name": "SORBITAN MONOSTEARATE",
            "code": "NVZ4I0H58X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_183394"
        },
        {
            "name": "STEARYL ALCOHOL",
            "code": "2KR89I4H1Y",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30879"
        }
    ],
    "indications": [
        {
            "text": "1 INDICATIONS AND USAGE Ivermectin cream is indicated for the treatment of inflammatory lesions of rosacea. Ivermectin cream is indicated for the treatment of inflammatory lesions of rosacea. ( 1 )",
            "doid_id": "http://purl.obolibrary.org/obo/DOID_8881",
            "orphanet_id": null
        }
    ],
    "contraindications": [
        {
            "text": "4 CONTRAINDICATIONS None. None. ( 4 )",
            "doid_id": null,
            "orphanet_id": null
        }
    ],
    "warningsAndPrecautions": null,
    "adverseReactions": "6 ADVERSE REACTIONS In controlled clinical trials with ivermectin cream the most common adverse reactions ( incidence \u2264 1 % ) included skin burning sensation and skin irritation. ( 6.1 ) To report SUSPECTED ADVERSE REACTIONS, contact Padagis \u00ae at 1-866-634-9120 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. 6.1 Clinical Trials Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice. During clinical trials, 2047 subjects with inflammatory lesions of rosacea received ivermectin cream once daily. A total of 1555 subjects were treated once daily for more than 12 weeks, and 519 for approximately one year. Adverse reactions, reported in \u2264 1% of subjects treated with ivermectin cream for at least 3 months in vehicle-controlled clinical trials, included skin burning sensation and skin irritation. 6.2 Postmarketing Experience Because adverse reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure. Local adverse reactions: contact dermatitis and allergic dermatitis.",
    "drug": [
        {
            "name": "Ivermectin",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_6078"
        }
    ]
}